Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Xiao, J ^a,b   Tian, X M ^c   Yang, C ^b   Liu, P ^a   Luo, N Q ^a   Liang, Y ^a   Li, H B ^a   Chen, D H ^a   Wang, C X ^a   Li, L ^b   Yang, G W ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; MANGANESE DERIVATIVE; MANGANESE OXIDE; METAL NANOPARTICLE; OXIDE;

ANIMAL; CHEMISTRY; DIAGNOSTIC USE; DISEASE MODEL; FEMALE; MALE; MOUSE; NEOPLASMS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; ULTRASTRUCTURE; XENOGRAFT;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; HETEROGRAFTS; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE COMPOUNDS; METAL NANOPARTICLES; MICE; NEOPLASMS; OXIDES;

EID: 84890034588     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03424     Document Type: Article

References (55)

1. Belliveau, J. W. et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 254, 716-719 (1991). (Pubitemid 21917395)
2. Kwong, K. K. et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. P. Natl. Acad. Sci 89, 5675-5679 (1992).
3. Sereno, M. I. et al. Borders of multiple visual areas in humans revealed by functional magnetic resonance imaging. Science 268, 889-893 (1995).
4. Weissleder, R. & Pittet, M. J. Imaging in the era of molecular oncology. Nature 452, 580-9 (2008). (Pubitemid 351483372)
5. Louie, A. Multimodality Imaging Probes: Design and Challenges. Chem. Rev. 110, 3146-3195 (2010).
6. Park, Y. Il et al. Nonblinking and Nonbleaching Upconverting Nanoparticles as an Optical Imaging Nanoprobe and T1 Magnetic Resonance Imaging Contrast Agent. Adv. Mater. 21, 4467-4471 (2009).
7. Ananta, J. S. et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nature 5, 815-821 (2010).
8. Cheng, Z., Thorek, D. L. J. & Tsourkas, A. Gadolinium-Conjugated Dendrimer Nanoclusters as a Tumor-Targeted T1 Magnetic Resonance Imaging Contrast Agent. Angew. Chem. Int. Ed. 49, 346-350 (2010).
9. Caravan, P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev. 35, 512-523 (2006). (Pubitemid 43815285)
10. Caravan, P., Ellison, J. J., McMurry, T. J. & Lauffer, R. B. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem. Rev. 99, 2293-2352 (1999). (Pubitemid 30498114)
11. Lauffer, R. E. Paramagnetic Metal Complexes as Water Proton Relaxation Agents for NMR Imaging: Theory and Design. Chem. Rev. 87, 901-27 (1987).
12. Idée, J.-M., Port, M., Dencausse, A., Lancelot, E. & Corot, C. Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An Update. Radiol. Clin. North Am. 47, 855-869 (2009).
13. Langer, R. D. et al. In an animal model nephrogenic systemic fibrosis cannot be induced by intraperitoneal injection of high-dose gadolinium based contrast agents. Eur. J. Radiol. 81, 2562-2567 (2012).
14. Thomsen, H. et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur. Radiol. 23, 307-318 (2013).
15. Na, H. Bin, Song, I. C. & Hyeon, T. Inorganic Nanoparticles for MRI Contrast Agents. Adv. Mater. 21, 2133-2148 (2009).
16. Jun, Y., Seo, J. & Cheon, J. Nanoscaling Laws of Magnetic Nanoparticles and Their Applicabilities in Biomedical Sciences. Acc. Chem. Res. 41, 179-189 (2008).
17. Hao, R. et al. Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles. Adv. Mater. 22, 2729-2742 (2010).
18. Thanh, N. T. K. & Green, L. A. W. Functionalisation of nanoparticles for biomedical applications. Nano Today 5, 213-230 (2010).
19. Byrappa, K., Ohara, S. & Adschiri, T. Nanoparticles synthesis using supercritical fluid technology-towards biomedical applications. Adv. Drug. Deliver. Rev. 60, 299-327 (2008).
20. Yu, X., Wadghiri, Y. Z., Sanes, D. H. & Turnbull, D. H. In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat. Neurosci 8, 961-8 (2005).
21. Na, H. Bin et al. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew. Chem. Int. Ed. 46, 5397-401 (2007).
22. Shin, J. et al. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew. Chem. Int. Ed. 48, 321-4 (2009).
23. Kim, T. et al. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J. Am. Chem. Soc. 133, 2955-61 (2011).
24. Huang, C.-C., Khu, N.-H. & Yeh, C.-S. The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies. Biomaterials 31, 4073-8 (2010).
25. Hu, F. & Zhao, Y. S. Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes. Nanoscale 4, 6235-6243 (2012).
26. Fischer, H. C. & Chan, W. C. W. Nanotoxicity: the growing need for in vivo study. Curr. Opin. Biotech. 18, 565-571 (2007).
27. Dobrovolskaia, M. A. & McNeil, S. E. Immunological properties of engineered nanomaterials. Nat. Nano 2, 469-478 (2007). (Pubitemid 47220069)
28. Dobrovolskaia, M. A., Germolec, D. R. & Weaver, J. L. Evaluation of nanoparticle immunotoxicity. Nat. Nano 4, 411-414 (2009).
29. Schrand, A. M. et al. Metal-based nanoparticles and their toxicity assessment. Wires. Nanomed. Nanobi. 2, 544-568 (2010).
30. Shao, Y. et al. The properties of Gd2O3-assembled silica nanocomposite targeted nanoprobes and their application in MRI. Biomaterials 33, 6438-46 (2012).
31. Zhen, Z. & Xie, J. Development of Manganese-Based Nanoparticles as Contrast Probes for Magnetic Resonance Imaging. Theranostics 2, 45-54 (2012).
32. Yang, G. W. Laser Ablation in Liquids: Principles and Applications in the Preparation of Nanomaterials. (Pan Stanford publishing, 2012).
33. Liu, P., Cao, Y. L., Wang, C. X., Chen, X. Y. & Yang, G. W. Micro-and Nanocubes of Carbon with C 8-like and Blue Luminescence 2008. Nano Lett. 8, 2570-2575 (2008).
34. Liu, P., Cui, H., Wang, C. X. & Yang, G. W. From nanocrystal synthesis to functional nanostructure fabrication: laser ablation in liquid. Phys. Chem. Chem. Phys. 12, 3942-3952 (2010).
35. Yang, G. Laser ablation in liquids: Applications in the synthesis of nanocrystals. Prog. Mater. Sci. 52, 648-698 (2007). (Pubitemid 46321549)
36. Zeng, H. et al. Nanomaterials via Laser Ablation/Irradiation in Liquid: A Review. Adv. Funct. Mater. 22, 1333-1353 (2012).
37. Xiao, J., Liu, P., Liang, Y., Li, H. B. & Yang, G. W. Porous tungsten oxide nanoflakes for highly alcohol sensitive performance. Nanoscale 4, 7078-7083 (2012).
38. Liu, J., Liang, C., Tian, Z., Zhang, S.&Shao, G.Spontaneous Growth and Chemical Reduction Ability of Ge Nanoparticles. Sci. Rep. 3, 1741 (2013).
39. Di Castro, V. & Polzonetti, G. XPS study of MnO oxidation. J. Electron Spectrosc. Relat. Phen. 48, 117-123 (1989).
40. Ardizzone, S., Bianchi, C. L. & Tirelli, D. Mn3O4 and c-MnOOH powders, preparation, phase composition and XPS characterisation. Colloid Surface A 134, 305-312 (1998). (Pubitemid 28177511)
41. Kim, K. J. et al. Novel catalytic effects of Mn3O4 for all vanadium redox flow batteries. Chem. Commun. 48, 5455-5457 (2012).
42. Park, M. et al. Large-Scale Synthesis of Ultrathin Manganese Oxide Nanoplates and Their Applications to T1 MRI Contrast Agents. Chem. Mater. 23, 3318-3324 (2011).
43. Huang, J. et al. HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging. Chem. Commun. 46, 6684-6 (2010).
44. Yang, H. et al. Silica-Coated Manganese Oxide Nanoparticles as a Platform for Targeted Magnetic Resonance and Fluorescence Imaging of Cancer Cells. Adv. Funct. Mater. 20, 1733-1741 (2010).
45. Taylor, K. M. L., Rieter, W. J. & Lin, W. Manganese-Based Nanoscale Metal2Organic Frameworks for Magnetic Resonance Imaging. J. Am. Chem. Soc. 130, 14358-9 (2008).
46. Gilad, A. A. et al. MR tracking of transplanted cells with ''positive contrast'' using manganese oxide nanoparticles. Magn. Reson. Med. 60, 1-7 (2008). (Pubitemid 351956602)
47. Chen, Y. et al. Structure-property relationships in manganese oxide-mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery. Biomaterials 33, 2388-98 (2012).
48. Weinmann, H., Brasch, R., Press, W. & Wesbey, G. Characteristics ofgadolinium-DTPA complex: a potential NMR contrast agent. Am. J. Roentgenol. 142, 619-624 (1984). (Pubitemid 14199123)
49. Luo, N. et al. High longitudinal relaxivity of ultra-small gadolinium oxide prepared by microsecond laser ablation in diethylene glycol. J. Appl. Phys. 113, 164306 (2013).
50. Bloembergen, N. & Morgan, L. O. Proton Relaxation Times in Paramagnetic Solutions. Effects of Electron Spin Relaxation. J. Chem. Phys. 34, 842 (1961).
51. Solomon, I.Relaxation Processesin aSystemof Two Spins. Phys. Rev. 99, 559-565 (1955).
52. Bloembergen, N. Proton Relaxation Times in Paramagnetic Solutions. J. Chem. Phys. 27, 572-573 (1957).
53. L. Villaraza, A.J., Bumb, A.&Brechbiel, M. W. Macromolecules, Dendrimers, and Nanomaterials in Magnetic Resonance Imaging: The Interplay between Size, Function, and Pharmacokinetics. Chem. Rev. 110, 2921-2959 (2010).
54. Singh, M. K. et al. Dumbbell shaped nickel nanocrystals synthesized by a laser induced fragmentation method. J. Mater. Chem. 21, 11074-11079 (2011).
55. 4 Nanowires. Adv. Mater. 11, 837-840 (2002) (Pubitemid 34697630)